On 2026-11-12, Parabilis Medicines, Inc. (PBLS) announced earnings per share of $-0.36 for the fiscal quarter ending 2026-09-30, beating the average analyst estimate of $-0.40.

The next expected annoucement date for quarterly earnings is 2027-02-11, with an average estimated earnings per share of $-0.36 for the fiscal quarter ending 2026-12-31.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.